Skip to main navigation
 
Search
Zentalis
Top Navigation
  • About Us
    • Our Company
      • Management Team
      • Board of Directors
      • Scientific Advisory Board
      • Business Advisory Board
      • Partners & Collaborations
    • Contact Us
  • Our Pipeline
    • Pipeline
      • ZN-c3
      • ZN-d5
    • Clinical Trials
  • Our Approach
    • Integrated Discovery Engine
    • Supporting Publications
  • Investors & Media
    • Investor Home
    • News & Events
      • Press Releases
      • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Financials & Filings
      • SEC Filings
    • Corporate Governance
      • Documents & Charters
      • Management Team
      • Board of Directors
      • Scientific Advisory Committee
      • Committee Composition
    • Investor Resources
      • Investor FAQs
      • Investor Contact
      • Email Alerts
  • Careers
    • Why Zentalis?
    • Job Opportunities

Investors & Media

SEC Filing Details

SEC Filing Details

Document Details

Form
10-Q
Filing Date
Nov 9, 2022
Document Date
Sep 30, 2022
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Zentalis Pharmaceuticals
Issuer
ZENTALIS PHARMACEUTICALS, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
XML - XBRL INSTANCE DOCUMENT

Investors/Media

  • Investor Home
  • News & Events
    • Press Releases
    • Events & Presentations
  • Stock Information
    • Stock Quote & Chart
    • Historic Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Financials & Filings
    • SEC Filings
  • Corporate Governance
    • Documents & Charters
    • Management Team
    • Board of Directors
    • Scientific Advisory Committee
    • Committee Composition
  • Investor Resources
    • Investor FAQs
    • Investor Contact
    • Email Alerts

Investor Contact

Adam Levy
Senior Vice President,
Investor Relations
alevy@zentalis.com

Alexandra Roy
Solebury Strategic Communications
aroy@soleburystrat.com

Media Contact

Julia Deutsch
Solebury Strategic Communications
jdeutsch@soleburystrat.com

“The sun is but a morning star.”

Zentalis Logo

Corporate Office

1359 Broadway
Suite 1710
New York, NY 10018

Science Center

10275 Science Center Dr.
Suite 200
San Diego, CA 92121

For More Information

1-212-433-3791
info@zentalis.com
Footer
  • Privacy Policy
  • Terms of Use
  • Expanded Access Policy
  • Site Map

Copyright © 2023 Zentalis Pharmaceuticals. All Rights Reserved.